Calidi Biotherapeutics Files 8-K on Financials
Ticker: CLDWW · Form: 8-K · Filed: Mar 18, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Mar 18, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, disclosure, company-name-change
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics dropped an 8-K on March 18th detailing their financial condition as of March 15th.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on March 18, 2024, reporting on its results of operations and financial condition as of March 15, 2024. The filing also includes Regulation FD disclosures and financial statements. The company was formerly known as First Light Acquisition Group, Inc. before changing its name on April 6, 2021.
Why It Matters
This 8-K filing provides an update on Calidi Biotherapeutics' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not appear to contain any new material risks or adverse events.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former company name
- March 15, 2024 (date) — Date of earliest event reported
- March 18, 2024 (date) — Date of report
- April 6, 2021 (date) — Date of name change
FAQ
What is the primary purpose of this Form 8-K filing for Calidi Biotherapeutics, Inc.?
The primary purpose of this Form 8-K filing is to report on the Results of Operations and Financial Condition of Calidi Biotherapeutics, Inc., as well as to provide Regulation FD Disclosures and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on March 15, 2024.
What was Calidi Biotherapeutics, Inc. formerly known as?
Calidi Biotherapeutics, Inc. was formerly known as First Light Acquisition Group, Inc.
On what date did the company change its name from First Light Acquisition Group, Inc.?
The company changed its name from First Light Acquisition Group, Inc. on April 6, 2021.
In which state is Calidi Biotherapeutics, Inc. incorporated?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
Filing Stats: 562 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-03-18 08:41:04
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex99-1.htm (EX-99.1) — 66KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-010208.txt ( ) — 339KB
- cldi-20240315.xsd (EX-101.SCH) — 4KB
- cldi-20240315_def.xml (EX-101.DEF) — 26KB
- cldi-20240315_lab.xml (EX-101.LAB) — 36KB
- cldi-20240315_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on our behalf by the undersigned hereunto duly authorized. Calidi Biotherapeutics, Inc. Dated: March 18, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer